NASDAQ:SPRB

Spruce Biosciences Stock Insider Trading

etoro logo Buy SPRB
*Your capital is at risk
$42.83
-0.540 (-1.25%)
At Close: Jul 31, 2026

Spruce Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -11.35. In total, the insiders bought 146.94K and sold 31.93K SPRB shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-11.35
Buy 146.94K shares
Sell 31.93K shares
65% Buy Activity
Weak Negative Correlation
Buy Signal Low Confidence
Jul 27, 2026

Analysis Breakdown:

  • Weakened by a contradictory negative Insider Power Score.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Dec 11, 2025
Buy
Restricted Stock Units
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 4 950
Value: $440.5K
Dec 11, 2025
Buy
Restricted Stock Units
A-Award
Gharib Samir M.
President And CFO
CEO / President 7 600
Value: $676.3K
Dec 11, 2025
Buy
Common Stock
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 1 900
Value: $169.1K
Dec 11, 2025
Sell
Common Stock
F-InKind
Gharib Samir M.
President And CFO
CEO / President 680
Value: $60.1K
Dec 11, 2025
Buy
Restricted Stock Units
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 1 900
Value: $169.1K
Dec 11, 2025
Buy
Restricted Stock Units
A-Award
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 19 800
Value: $1.76M
Dec 11, 2025
Buy
Common Stock
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 4 950
Value: $440.5K
Dec 11, 2025
Sell
Common Stock
F-InKind
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 2 194
Value: $194.0K
Dec 10, 2025
Buy
Restricted Stock Units
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 196
Value: $102.7K
Dec 10, 2025
Sell
Common Stock
F-InKind
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 428
Value: $36.7K
Dec 10, 2025
Buy
Common Stock
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 196
Value: $102.7K
Dec 10, 2025
Buy
Common Stock
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 514
Value: $44.2K
Dec 10, 2025
Sell
Common Stock
F-InKind
Gharib Samir M.
President And CFO
CEO / President 184
Value: $15.8K
Dec 10, 2025
Buy
Restricted Stock Units
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 514
Value: $44.2K
Oct 20, 2025
Buy
Restricted Stock Units
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 4 784
Value: $708.8K
Oct 20, 2025
Sell
Common Stock
F-InKind
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 1 539
Value: $228.0K
Oct 20, 2025
Buy
Restricted Stock Units
A-Award
Gharib Samir M.
President And CFO
CEO / President 2 053
Value: $304.2K
Oct 20, 2025
Sell
Common Stock
F-InKind
Gharib Samir M.
President And CFO
CEO / President 661
Value: $97.9K
Oct 20, 2025
Buy
Common Stock
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 2 053
Value: $304.2K
Oct 20, 2025
Buy
Restricted Stock Units
M-Exempt
Gharib Samir M.
President And CFO
CEO / President 2 053
Value: $304.2K
Oct 20, 2025
Buy
Common Stock
M-Exempt
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 4 784
Value: $708.8K
Oct 20, 2025
Buy
Restricted Stock Units
A-Award
Szwarcberg Javier B.
Chief Executive Officer
CEO / President 4 784
Value: $708.8K
Oct 06, 2025
Buy
Common Stock, $0.001 par value per share
P-Purchase
Parkman Healthcare Partners Llc
10 Percent Owner
10% Owner 256
Value: $5K
Oct 06, 2025
Sell
Common Stock, $0.001 par value per share
S-Sale
Parkman Healthcare Partners Llc
10 Percent Owner
10% Owner 232
Value: $4K
Oct 06, 2025
Sell
Common Stock, $0.001 par value per share
S-Sale
Parkman Healthcare Partners Llc
10 Percent Owner
10% Owner 25
Value: $436

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT SPRUCE BIOSCIENCES, INC.
Spruce Biosciences
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adu...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE